Author: Josh Barney (Page 15)

A booster makes for longer-lasting antibodies, even for those who have had COVID-19, new research shows.

Our Ishan Williams, PhD, and Randall Moorman, MD, have received almost $6 million from the National Institutes of Health to capitalize on the untapped potential of artificial intelligence to improve critical care.

A surprise finding from our Wladek Minor should improve the process of drug development and help prevent harmful drug interactions.

Our Golam Mohi, PhD, has identified a promising new treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.

Here's an interesting article on how cautious infectious-disease experts are being about COVID-19 this Thanksgiving, nearly three years into the pandemic.

A portable "hydrogel" called Volumatrix could change how we treat traumatic injuries both on the battlefield and off.